Thailand is a Land of Opportunity
Thailand is indeed a nation of opportunities. It is a developing country with a growing economy, and it offers a number of advantages for businesses and individuals alike.
Here are some of the reasons why Thailand is a nation of opportunities:
A young and growing population: Thailand has a young population with a median age of 37 years old. This means that there is a large pool of potential workers available, and the country is well-positioned to benefit from demographic trends.
A growing economy: Thailand's economy has been growing steadily for many years, and it is expected to continue to grow in the coming years. This growth is being driven by a number of factors, including tourism, manufacturing, and exports.
A favorable business environment: Thailand has a relatively favorable business environment, with low corporate taxes and a relatively stable political system. This makes it an attractive destination for businesses looking to expand into Asia.
A strong tourism industry: Thailand is a popular tourist destination, and it is expected to remain so in the coming years. This provides opportunities for businesses in the tourism sector, such as hotels, restaurants, and tour operators.
A vibrant culture: Thailand has a rich and vibrant culture, which makes it an attractive place to live and work. There is a strong sense of community in Thailand, and the people are generally friendly and welcoming.
Here are some specific examples of opportunities in Thailand:
Tourism: Thailand is a popular tourist destination, and the tourism industry is expected to continue to grow in the coming years. This provides opportunities for businesses in the tourism sector, such as hotels, restaurants, and tour operators.
Manufacturing: Thailand is a major manufacturing hub, and it is home to a number of multinational corporations. This provides opportunities for businesses in the manufacturing sector, such as electronics, textiles, and food processing.
Agriculture: Thailand is a major agricultural producer, and it is the world's leading exporter of rice. This provides opportunities for businesses in the agriculture sector, such as food processing, fertilizer production, and agricultural machinery.
Education: Thailand is a rapidly growing economy, and there is a growing demand for skilled workers. This provides opportunities for businesses in the education sector, such as universities, language schools, and vocational training centers.
Healthcare: Thailand has a strong healthcare system, and it is becoming a regional hub for medical tourism. This provides opportunities for businesses in the healthcare sector, such as hospitals, clinics, and medical tourism agencies.
If you are looking for opportunities, Thailand is a great place to start. The country has a lot to offer businesses and individuals alike, and the opportunities are only going to grow in the coming years.

Phonons: The Particles of Vibration, From Constraint to Control
A phonon is one quantum of lattice vibration. Phonons carry the heat that limits AI chips, make the radio filters in phones work and are the moving part of trapped-ion quantum computers. In superconducting quantum chips they are the threat: a particle hit spreads through the chip as phonons and causes error bursts. Four results between 12 October and 20 November 2026 measured, steered and modelled them with new precision.

AI Sell-Off Is Noise and Demand Is Rising
In my view the AI sell-off is noise. Anthropic priced its IPO at $83 on 18 November 2026 and closed its first day at $97.17. NVIDIA reported a $115.8 billion quarter and guided to $130 billion, yet closed at $125.53 on 20 November 2026, 47.5% below its record. Ramp puts paid business adoption of AI at 56.8%, up 1 point. KXCO's AI ontology ranks Oracle, Alibaba and NVIDIA as the three profitable names with the most upside to the analysts' targets.

KXCO Three for Three on FDA Decisions
The FDA has ruled on three drugs on KXCO's FDA board since we set our model books in October 2026, and all three are wins for the books. They held INO-3107, and the FDA approved it on 30 October. They held neither ivonescimab nor deramiocel, and the FDA refused both. Per the books' public ledger and Yahoo Finance closes, from 14 October to 20 November 2026, Book 1 rose 0.9% and Book 2 rose 2.1%, while the S&P 500 fell 10.5%, the Nasdaq 15.3%, the Dow 6.7% and XBI 4.5%.

KXCO's FDA Ontology Is Two for Two on FDA Decisions
The FDA has decided two filings on KXCO's FDA board since the board began ranking them, and on my scorecard the board got both right. It ranked Inovio's INO-3107 first and the FDA approved it on 30 October; Inovio moved +149.1% net of the sector. It gave Summit's ivonescimab no call, and Summit announced the FDA's refusal on 15 November; Summit fell 16.5%. KXCO's record held the FDA's survival warning before the refusal was announced.
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.